Hanseatic Management Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-6,472
Closed -$959K 180
2020
Q2
$959K Sell
6,472
-2,253
-26% -$304K 0.81% 41
2020
Q1
$950K Buy
8,725
+2,346
+37% +$271K 1.01% 23
2019
Q4
$735K Buy
+6,379
New +$636K 0.67% 68
2018
Q4
Sell
-246
Closed -$22K 254
2018
Q3
$22K Sell
246
-4,903
-95% -$493K 0.02% 215
2018
Q2
$507K Sell
5,149
-5
-0.1% -$496 0.44% 88
2018
Q1
$614K Sell
5,154
-14
-0.3% -$1.8K 0.59% 69
2017
Q4
$657K Buy
5,168
+123
+2% +$15.5K 0.66% 59
2017
Q3
$593K Sell
5,045
-2,575
-34% -$220K 0.67% 55
2017
Q2
$608K Buy
+7,620
New +$487K 0.31% 119
2015
Q3
Sell
-11,944
Closed -$1.43M 356
2015
Q2
$1.43M Buy
11,944
+6,008
+101% +$718K 0.63% 53
2015
Q1
$620K Sell
5,936
-22,164
-79% -$2.25M 0.33% 89
2014
Q4
$2.73M Buy
+28,100
New +$2.6M 1.4% 10

Other funds holding ALNY

Hanseatic Management Services's ALNY Position: Q3 2020 in Review

Hanseatic Management Services sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2020, closing a stake of 6,472 shares — an estimated $959K sold.

Hanseatic Management Services first reported a position in ALNY in Q4 2014 and held it in 12 quarters. The position peaked at $2.73M in Q4 2014. 357 funds tracked by Wall St. Rank hold ALNY as of Q3 2020.

  • Hanseatic Management Services reported no remaining Alnylam Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Hanseatic Management Services sold 6,472 Alnylam Pharmaceuticals shares in Q3 2020, an estimated $959K.
  • Hanseatic Management Services first reported a position in Alnylam Pharmaceuticals in Q4 2014 and held it in 12 quarters.
  • Hanseatic Management Services's Alnylam Pharmaceuticals position peaked at $2.73M in Q4 2014.
  • 357 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2020.

Based on Hanseatic Management Services's 13F filing for Q3 2020, filed 29 Oct 2020.